""

Pleural mesothelioma

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

Title: Nivolumab with chemotherapy in pleural mesothelioma after surgery
Phase: II
Contact: Petra Kettenring / (Kontaktperson)
Clinical Investigator: Dr. Rajiv Shah
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04177953
EudraCT-Number: siehe EU klinisches Studienregister 2019-002466-13

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Care

There are currently no studies available

Other study

There are currently no studies available